Wells Fargo’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
FDCDDQ
CCA
AWM
KF
OIA
CGA
Wells Fargo's BTAL Position: Q2 2026 in Review
Wells Fargo held its AGF US Market Neutral Anti-Beta Fund (BTAL) position steady in Q2 2026 at 63 shares worth $700. The position accounts for ﹤0.01% of the portfolio, ranked #6486.
Wells Fargo first reported a position in BTAL in Q4 2019 and has held it in 19 quarters since. The position peaked at $71.7K in Q1 2023. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.
- Wells Fargo held 63 shares of AGF US Market Neutral Anti-Beta Fund worth $700 as of Q2 2026.
- Wells Fargo left its AGF US Market Neutral Anti-Beta Fund share count unchanged in Q2 2026.
- AGF US Market Neutral Anti-Beta Fund made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6486 holding.
- Wells Fargo first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2019 and has held it in 19 quarters since.
- Wells Fargo's AGF US Market Neutral Anti-Beta Fund position peaked at $71.7K in Q1 2023.
- 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.